In every book that you read about technical analysis everyone mentions how important trend identification and its reversals are and that a trend is made up of higher tops and higher bottoms a head and shoulders of a left shoulder a right shoulder and a head and so on. In order however to be able […]
Continue ReadingRisk appetite waned the past week as the number of new global COVID-19 cases continued to surge. The outbreak in the US is continuing to worsen, The country recorded 45,242 new cases of COVID-19 on Friday, the largest single-day increase of the pandemic and thus several states took steps back from efforts to ease restrictions […]
Continue ReadingRisk appetite faded clearly since the middle of the past week. On Wednesday, the Fed took no actions and signaled that the interest rates will remain low for long time period, and policymakers were clear that they will keep their stimulus measures until the economy improves and they assured that they are ready to take […]
Continue ReadingRisk sentiments continued improving over the past week driving risk assets higher, and weighing on safe havens including the US dollar which ended the week lower for the third consecutive time. The greenback could only post some gains against the other safe-havens, mainly the yen and Swiss Franc. Investors appeared to shrug off recent concerning […]
Continue ReadingRisk sentiments weakened last week weighed by worries about Sino-U.S. trade relations and weaker-than-expected U.S. Economic data painted a grim picture at the end of the past week as U.S. retail sales and manufacturing output showed record declines in April due to virus-related stay-at-home orders. Retail sales plummeted by 16.4%, a decline never seen before […]
Continue ReadingAfter having improved earlier in the past week on promising coronavirus drug and hope of shutdowns ending soon, risk sentiments saw a turnaround on Thursday on fears that the US-China trade could resume. The US president Donald Trump who was accusing China for not giving enough warning about the coronavirus, has hinted at new tariffs […]
Continue ReadingRisk sentiment remained volatile the past week. The United States is deeply divided over the correct economic and health response. Until now, no drugs or other therapeutics presently approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. On Thursday, the leading experimental drug Remdesivir that had been heralded as a […]
Continue ReadingRisk sentiment improved at the end of the past week and world stocks closed higher for the second week in a row. It seems like investors decided to ignore the raft of gloomy data and corporate earnings released over the week and focus on positive developments. They were optimistic about the results of a drug […]
Continue ReadingRisk sentiment has steadily improved the past week on tentative signs that the pandemic is slowing in U.S. and European hotspots, and bolstered by the U.S. Federal Reserve’s massive new lending programme for small companies. The Fed on Thursday announced a $2.3 trillion programme to offer loans to local governments and small and mid-sized businesses, […]
Continue ReadingFear remains in the air, and although there are some signs that the number of new infections in Europe is slowing, in the US the number of new cases is continuing to rise. The global number of infections has passed one million during the past week, with the US having roughly a quarter of the […]
Continue Reading
